SIMILAR PATTERNS OF AMINO ACIDS FOR 5KR1_B_017B101_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e43 ALPHA-AMYLASE

(Bacillus
amyloliquefaciens)
PF00128
(Alpha-amylase)
PF09154
(DUF1939)
4 GLY A 106
ALA A 107
ASP A 108
ASP A 138
None
0.46A 5kr1B-1e43A:
undetectable
5kr1B-1e43A:
12.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
4 ALA A  28
ASP A  29
VAL A  32
GLY A  48
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.4A)
A79  A 800 (-3.6A)
0.64A 5kr1B-1hvcA:
13.7
5kr1B-1hvcA:
44.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
0.55A 5kr1B-1hvcA:
13.7
5kr1B-1hvcA:
44.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
0.54A 5kr1B-1hvcA:
13.7
5kr1B-1hvcA:
44.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1olx 2-OXOISOVALERATE
DEHYDROGENASE BETA
SUBUNIT


(Homo sapiens)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 GLY B  90
ALA B  91
VAL B  42
GLY B  83
ILE B  84
None
1.38A 5kr1B-1olxB:
undetectable
5kr1B-1olxB:
17.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
None
0.47A 5kr1B-1q9pA:
10.0
5kr1B-1q9pA:
93.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
None
0.60A 5kr1B-1sivA:
18.0
5kr1B-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tlg POLYANDROCARPA
LECTIN


(Polyandrocarpa
misakiensis)
PF00059
(Lectin_C)
4 GLY A  56
ALA A  57
ASP A  58
GLY A  72
None
0.61A 5kr1B-1tlgA:
undetectable
5kr1B-1tlgA:
17.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1w8j MYOSIN VA

(Gallus gallus)
PF00063
(Myosin_head)
5 ALA A 173
ASP A 437
VAL A 161
GLY A 434
ILE A 433
None
1.50A 5kr1B-1w8jA:
undetectable
5kr1B-1w8jA:
9.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x0u HYPOTHETICAL
METHYLMALONYL-COA
DECARBOXYLASE ALPHA
SUBUNIT


(Sulfurisphaera
tokodaii)
PF01039
(Carboxyl_trans)
4 GLY A 424
ALA A 425
ASP A 426
ILE A 354
None
0.52A 5kr1B-1x0uA:
undetectable
5kr1B-1x0uA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x7f OUTER SURFACE
PROTEIN


(Bacillus cereus)
PF05913
(DUF871)
4 GLY A  92
ALA A  93
ASP A  94
ILE A  55
None
0.60A 5kr1B-1x7fA:
undetectable
5kr1B-1x7fA:
12.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yw6 SUCCINYLGLUTAMATE
DESUCCINYLASE


(Escherichia
coli)
PF04952
(AstE_AspA)
4 GLY A 180
ALA A 179
GLY A 242
ILE A 243
None
0.66A 5kr1B-1yw6A:
undetectable
5kr1B-1yw6A:
15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2di4 CELL DIVISION
PROTEIN FTSH HOMOLOG


(Aquifex
aeolicus)
PF01434
(Peptidase_M41)
4 GLY A 492
ALA A 493
ASP A 496
ILE A 417
None
None
HG  A1001 (-2.3A)
None
0.67A 5kr1B-2di4A:
undetectable
5kr1B-2di4A:
16.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 GLY A 186
ALA A 185
VAL A 169
GLY A 154
ILE A 153
BTX  A 501 (-3.3A)
None
None
None
None
1.46A 5kr1B-2ewnA:
undetectable
5kr1B-2ewnA:
17.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  54
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.6A)
0.72A 5kr1B-2fmbA:
15.2
5kr1B-2fmbA:
33.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  55
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
None
LP1  A 201 (-3.4A)
0.46A 5kr1B-2fmbA:
15.2
5kr1B-2fmbA:
33.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fw2 TESTIS-SPECIFIC
CHROMODOMAIN PROTEIN
Y 2


(Homo sapiens)
PF00378
(ECH_1)
4 ASN A 108
GLY A 109
VAL A 105
GLY A 115
None
0.57A 5kr1B-2fw2A:
undetectable
5kr1B-2fw2A:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gwc GLUTAMATE CYSTEINE
LIGASE


(Brassica juncea)
PF04107
(GCS2)
4 GLY A 388
ALA A 389
ASP A 390
ILE A 270
None
0.53A 5kr1B-2gwcA:
undetectable
5kr1B-2gwcA:
11.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
0.40A 5kr1B-2rkfA:
20.4
5kr1B-2rkfA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vn8 RETICULON-4-INTERACT
ING PROTEIN 1


(Homo sapiens)
PF08240
(ADH_N)
PF13602
(ADH_zinc_N_2)
4 GLY A 248
ALA A 249
ASP A 250
ASP A 251
None
0.61A 5kr1B-2vn8A:
undetectable
5kr1B-2vn8A:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wd9 ACYL-COENZYME A
SYNTHETASE ACSM2A,
MITOCHONDRIAL


(Homo sapiens)
PF00501
(AMP-binding)
PF13193
(AMP-binding_C)
4 GLY A 280
ALA A 281
ASP A 255
GLY A 247
None
0.62A 5kr1B-2wd9A:
undetectable
5kr1B-2wd9A:
11.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtb FATTY ACID
MULTIFUNCTIONAL
PROTEIN (ATMFP2)


(Arabidopsis
thaliana)
PF00378
(ECH_1)
PF00725
(3HCDH)
PF02737
(3HCDH_N)
4 ALA A 497
VAL A 488
GLY A 658
ILE A 671
None
0.64A 5kr1B-2wtbA:
undetectable
5kr1B-2wtbA:
7.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y9e MYOSIN-2

(Dictyostelium
discoideum)
PF00063
(Myosin_head)
PF02736
(Myosin_N)
4 GLY X 255
ALA X 256
GLY X 451
ILE X 450
None
0.63A 5kr1B-2y9eX:
undetectable
5kr1B-2y9eX:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yjt ATP-DEPENDENT RNA
HELICASE SRMB


(Escherichia
coli)
PF00271
(Helicase_C)
4 ALA D 229
ASP D 230
ASP D 231
ILE D 376
None
0.66A 5kr1B-2yjtD:
undetectable
5kr1B-2yjtD:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yjv REGULATOR OF
RIBONUCLEASE
ACTIVITY A


(Escherichia
coli)
PF03737
(RraA-like)
4 GLY A  67
ASP A  64
VAL A  91
GLY A 134
None
0.57A 5kr1B-2yjvA:
undetectable
5kr1B-2yjvA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zki 199AA LONG
HYPOTHETICAL TRP
REPRESSOR BINDING
PROTEIN


(Sulfurisphaera
tokodaii)
PF03358
(FMN_red)
4 GLY A 162
ALA A 163
GLY A 184
ILE A 187
None
0.59A 5kr1B-2zkiA:
undetectable
5kr1B-2zkiA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3be7 ZN-DEPENDENT
ARGININE
CARBOXYPEPTIDASE


(unidentified)
PF01979
(Amidohydro_1)
4 GLY A 317
ASP A 320
ASP A 323
ILE A 272
GOL  A 502 (-3.6A)
None
None
None
0.56A 5kr1B-3be7A:
undetectable
5kr1B-3be7A:
14.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c8o REGULATOR OF
RIBONUCLEASE
ACTIVITY A


(Pseudomonas
aeruginosa)
PF03737
(RraA-like)
4 GLY A  67
ASP A  64
VAL A  91
GLY A 134
EDO  A 177 (-4.3A)
None
None
None
0.66A 5kr1B-3c8oA:
undetectable
5kr1B-3c8oA:
19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3etl DNA REPAIR AND
RECOMBINATION
PROTEIN RADA


(Methanococcus
maripaludis)
PF08423
(Rad51)
PF14520
(HHH_5)
4 GLY A 165
ALA A 166
GLY A  83
ILE A 320
None
0.60A 5kr1B-3etlA:
undetectable
5kr1B-3etlA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g7r PUTATIVE
TRANSCRIPTIONAL
REGULATOR


(Streptomyces
coelicolor)
PF00440
(TetR_N)
4 GLY A 166
ALA A 167
VAL A  99
GLY A 186
None
0.67A 5kr1B-3g7rA:
undetectable
5kr1B-3g7rA:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gmi UPF0348 PROTEIN
MJ0951


(Methanocaldococcus
jannaschii)
PF05636
(HIGH_NTase1)
PF16581
(HIGH_NTase1_ass)
4 GLY A 111
ALA A 112
ASP A 113
GLY A  73
None
0.61A 5kr1B-3gmiA:
undetectable
5kr1B-3gmiA:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
4 GLY A 121
ALA A 122
ASP A 123
ILE A  89
None
0.64A 5kr1B-3gveA:
undetectable
5kr1B-3gveA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hrx PROBABLE ENOYL-COA
HYDRATASE


(Thermus
thermophilus)
PF00378
(ECH_1)
4 ASN A  99
GLY A 100
VAL A  96
GLY A 106
None
0.54A 5kr1B-3hrxA:
undetectable
5kr1B-3hrxA:
17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hst PROTEIN
RV2228C/MT2287


(Mycobacterium
tuberculosis)
PF13456
(RVT_3)
5 ALA B 132
ASP B 131
ASP B 128
GLY B  19
ILE B  40
None
1.24A 5kr1B-3hstB:
undetectable
5kr1B-3hstB:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
None
0.68A 5kr1B-3i5gA:
undetectable
5kr1B-3i5gA:
8.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ke6 PROTEIN
RV1364C/MT1410


(Mycobacterium
tuberculosis)
PF07228
(SpoIIE)
PF13581
(HATPase_c_2)
4 GLY A 175
ALA A 176
ASP A 177
GLY A 320
None
0.58A 5kr1B-3ke6A:
undetectable
5kr1B-3ke6A:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3m8y PHOSPHOPENTOMUTASE

(Bacillus cereus)
PF01676
(Metalloenzyme)
5 ASP A 286
ASP A  13
VAL A  11
GLY A  16
ILE A  34
MN  A 395 (-2.2A)
MN  A 396 (-2.0A)
None
None
None
1.36A 5kr1B-3m8yA:
undetectable
5kr1B-3m8yA:
14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mmp ELONGATION FACTOR TU
2, ELONGATION FACTOR
TS


(Escherichia
coli)
PF00009
(GTP_EFTU)
PF00889
(EF_TS)
PF03143
(GTP_EFTU_D3)
PF03144
(GTP_EFTU_D2)
4 GLY A1316
ASP A1314
GLY A1353
ILE A1310
None
0.65A 5kr1B-3mmpA:
undetectable
5kr1B-3mmpA:
10.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
None
0.62A 5kr1B-3mwsA:
19.7
5kr1B-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
None
0.47A 5kr1B-3mwsA:
19.7
5kr1B-3mwsA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
None
0.46A 5kr1B-3mwsA:
19.7
5kr1B-3mwsA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oox PUTATIVE 2OG-FE(II)
OXYGENASE FAMILY
PROTEIN


(Caulobacter
vibrioides)
PF03171
(2OG-FeII_Oxy)
PF14226
(DIOX_N)
4 GLY A  88
ALA A  89
ASP A  90
GLY A 188
None
0.57A 5kr1B-3ooxA:
undetectable
5kr1B-3ooxA:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 512
ALA A 231
VAL A 268
GLY A 236
ILE A 213
None
1.21A 5kr1B-3opyA:
undetectable
5kr1B-3opyA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r0z D-SERINE DEHYDRATASE

(Salmonella
enterica)
PF00291
(PALP)
4 ASN A  27
GLY A  29
ALA A  30
GLY A  36
None
0.53A 5kr1B-3r0zA:
undetectable
5kr1B-3r0zA:
12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rm5 HYDROXYMETHYLPYRIMID
INE/PHOSPHOMETHYLPYR
IMIDINE KINASE THI20


(Saccharomyces
cerevisiae)
PF03070
(TENA_THI-4)
PF08543
(Phos_pyr_kin)
4 GLY A 242
VAL A 124
GLY A 266
ILE A 267
SO4  A   1 (-3.3A)
None
None
None
0.67A 5kr1B-3rm5A:
undetectable
5kr1B-3rm5A:
12.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s99 BASIC MEMBRANE
LIPOPROTEIN


(Brucella
abortus)
PF02608
(Bmp)
4 GLY A 134
VAL A 245
GLY A 160
ILE A 161
None
0.65A 5kr1B-3s99A:
undetectable
5kr1B-3s99A:
17.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
4 GLY A  34
ALA A  35
VAL A  39
GLY A  56
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.66A 5kr1B-3slzA:
11.1
5kr1B-3slzA:
27.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  49
ILE A  50
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.22A 5kr1B-3t3cA:
18.8
5kr1B-3t3cA:
73.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t44 INDOLE-3-GLYCEROL
PHOSPHATE SYNTHASE


(Mycobacterium
tuberculosis)
PF00218
(IGPS)
4 GLY A 235
ALA A 236
ASP A 237
ILE A 206
None
0.67A 5kr1B-3t44A:
undetectable
5kr1B-3t44A:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tnx PAPAIN

(Carica papaya)
PF00112
(Peptidase_C1)
PF08246
(Inhibitor_I29)
4 ASN A 224
GLY A 226
ALA A 227
GLY A 104
None
0.52A 5kr1B-3tnxA:
undetectable
5kr1B-3tnxA:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3to4 NKT VBETA2 (MOUSE
VARIABLE DOMAIN,
HUMAN CONSTANT
DOMAIN)


(Homo sapiens;
Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
4 GLY D  63
ALA D  64
ASP D  65
GLY D  16
None
0.64A 5kr1B-3to4D:
undetectable
5kr1B-3to4D:
16.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-4.6A)
017  A 201 (-3.3A)
0.47A 5kr1B-3ttpA:
19.3
5kr1B-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
0.37A 5kr1B-3ttpA:
19.3
5kr1B-3ttpA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u07 UNCHARACTERIZED
PROTEIN VPA0106


(Vibrio
parahaemolyticus)
PF06742
(DUF1214)
PF06863
(DUF1254)
5 ASN A 160
GLY A 226
ASP A 158
ASP A 115
VAL A 162
None
1.27A 5kr1B-3u07A:
undetectable
5kr1B-3u07A:
11.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u5t 3-OXOACYL-[ACYL-CARR
IER-PROTEIN]
REDUCTASE


(Sinorhizobium
meliloti)
PF13561
(adh_short_C2)
4 GLY A  91
ALA A  90
GLY A  17
ILE A  16
None
0.67A 5kr1B-3u5tA:
undetectable
5kr1B-3u5tA:
17.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.33A 5kr1B-3u7sA:
19.9
5kr1B-3u7sA:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3umm PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
SYNTHASE


(Salmonella
enterica)
PF02769
(AIRS_C)
PF13507
(GATase_5)
4 GLY A 504
ALA A 505
GLY A 447
ILE A 446
ANP  A2001 ( 3.9A)
None
None
None
0.58A 5kr1B-3ummA:
undetectable
5kr1B-3ummA:
5.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wfz LACTO-N-BIOSE
PHOSPHORYLASE


(Bifidobacterium
longum)
PF09508
(Lact_bio_phlase)
PF17385
(LBP_M)
PF17386
(LBP_C)
4 GLY A  27
ALA A  28
ASP A  29
GLY A 398
None
0.66A 5kr1B-3wfzA:
undetectable
5kr1B-3wfzA:
8.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wj2 CARBOXYLESTERASE

(Ferroplasma
acidiphilum)
PF07859
(Abhydrolase_3)
5 GLY A 282
ASP A 251
VAL A   7
GLY A 276
ILE A 296
None
1.27A 5kr1B-3wj2A:
undetectable
5kr1B-3wj2A:
15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zyy IRON-SULFUR CLUSTER
BINDING PROTEIN


(Carboxydothermus
hydrogenoformans)
PF00111
(Fer2)
PF14574
(DUF4445)
4 GLY X 577
ALA X 578
GLY X 355
ILE X 357
None
0.62A 5kr1B-3zyyX:
undetectable
5kr1B-3zyyX:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bj4 AMPDH2

(Pseudomonas
aeruginosa)
PF01471
(PG_binding_1)
PF01510
(Amidase_2)
4 GLY A 230
ALA A 231
ASP A 155
GLY A 165
None
0.59A 5kr1B-4bj4A:
undetectable
5kr1B-4bj4A:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c1n IRON-SULFUR CLUSTER
BINDING PROTEIN


(Carboxydothermus
hydrogenoformans)
PF14574
(DUF4445)
4 GLY I 577
ALA I 578
GLY I 355
ILE I 357
None
0.67A 5kr1B-4c1nI:
undetectable
5kr1B-4c1nI:
13.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cuo BANYAN PEROXIDASE

(Ficus
benghalensis)
PF00141
(peroxidase)
5 GLY A  51
ALA A  98
ASP A  99
GLY A 283
ILE A 285
None
None
None
CL  A1331 ( 4.7A)
CO3  A1336 ( 4.9A)
1.32A 5kr1B-4cuoA:
undetectable
5kr1B-4cuoA:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dy5 GIFSY-1 PROPHAGE
PROTEIN


(Salmonella
enterica)
PF04151
(PPC)
4 ASN A  68
GLY A  70
ALA A  71
ASP A  72
None
None
None
GOL  A 202 (-3.1A)
0.60A 5kr1B-4dy5A:
undetectable
5kr1B-4dy5A:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e4y SHORT CHAIN
DEHYDROGENASE FAMILY
PROTEIN


(Francisella
tularensis)
PF13561
(adh_short_C2)
4 GLY A  76
ALA A  75
GLY A  14
ILE A  13
None
0.62A 5kr1B-4e4yA:
undetectable
5kr1B-4e4yA:
17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eut SERINE/THREONINE-PRO
TEIN KINASE TBK1


(Homo sapiens)
PF00069
(Pkinase)
4 GLY A 199
ALA A 200
ASP A 203
GLY A 130
None
0.57A 5kr1B-4eutA:
undetectable
5kr1B-4eutA:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fn5 ELONGATION FACTOR G
1


(Pseudomonas
aeruginosa)
PF00009
(GTP_EFTU)
PF00679
(EFG_C)
PF03144
(GTP_EFTU_D2)
PF03764
(EFG_IV)
PF14492
(EFG_II)
4 GLY A 571
ALA A 570
VAL A 698
GLY A 613
None
0.64A 5kr1B-4fn5A:
undetectable
5kr1B-4fn5A:
9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g9s INHIBITOR OF G-TYPE
LYSOZYME


(Escherichia
coli)
PF04151
(PPC)
4 ASN B  68
GLY B  70
ALA B  71
ASP B  72
None
0.56A 5kr1B-4g9sB:
undetectable
5kr1B-4g9sB:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hcy THIAMINASE-I

(Naegleria
gruberi)
no annotation 4 GLY A 296
ASP A 293
GLY A 307
ILE A 308
None
0.66A 5kr1B-4hcyA:
undetectable
5kr1B-4hcyA:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jyj ENOYL-COA
HYDRATASE/ISOMERASE


(Novosphingobium
aromaticivorans)
PF00378
(ECH_1)
4 ALA A 120
ASP A 121
GLY A  54
ILE A  19
None
0.63A 5kr1B-4jyjA:
undetectable
5kr1B-4jyjA:
17.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
ASP A  30
VAL A  32
GLY A  48
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
0.63A 5kr1B-4njvA:
20.2
5kr1B-4njvA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  32
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-4.8A)
None
0.46A 5kr1B-4njvA:
20.2
5kr1B-4njvA:
83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 GLY A  27
ALA A  28
ASP A  29
VAL A  32
GLY A  49
ILE A  50
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
0.54A 5kr1B-4njvA:
20.2
5kr1B-4njvA:
83.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o5h PHENYLACETALDEHYDE
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00171
(Aldedh)
5 ASP A 291
ASP A 289
VAL A 288
GLY A 324
ILE A 326
None
1.16A 5kr1B-4o5hA:
undetectable
5kr1B-4o5hA:
13.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ofq PUTATIVE CELL
SURFACE PROTEIN


(Streptococcus
pyogenes)
PF16364
(Antigen_C)
4 GLY A1269
ALA A1270
ASP A1271
GLY A1232
None
0.64A 5kr1B-4ofqA:
undetectable
5kr1B-4ofqA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ony EXTRACELLULAR
SOLUTE-BINDING
PROTEIN FAMILY 5


(Brucella
melitensis)
PF00496
(SBP_bac_5)
4 GLY A 381
ALA A 382
VAL A 524
GLY A 554
None
0.67A 5kr1B-4onyA:
undetectable
5kr1B-4onyA:
11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ra7 PEPTIDOGLYCAN
GLYCOSYLTRANSFERASE


(Atopobium
parvulum)
PF00905
(Transpeptidase)
4 GLY A 933
ALA A 934
GLY A 907
ILE A 906
None
0.55A 5kr1B-4ra7A:
undetectable
5kr1B-4ra7A:
12.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ttp DEPHOSPHO-COA KINASE

(Legionella
pneumophila)
PF01121
(CoaE)
5 ALA A 175
ASP A 176
ASP A 177
GLY A  12
ILE A 118
None
0.86A 5kr1B-4ttpA:
undetectable
5kr1B-4ttpA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u1r ATP-DEPENDENT
6-PHOSPHOFRUCTOKINAS
E, PLATELET TYPE


(Homo sapiens)
PF00365
(PFK)
5 GLY A 326
ALA A  45
VAL A  82
GLY A  50
ILE A  27
None
1.31A 5kr1B-4u1rA:
undetectable
5kr1B-4u1rA:
9.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uqz HSIB1
HSIE1


(Pseudomonas
aeruginosa)
PF05591
(T6SS_VipA)
PF07024
(ImpE)
4 ASN A  57
ASP A  88
VAL A  84
GLY B  29
None
0.65A 5kr1B-4uqzA:
undetectable
5kr1B-4uqzA:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yah D-METHIONINE-BINDING
LIPOPROTEIN METQ


(Escherichia
coli)
PF03180
(Lipoprotein_9)
4 GLY X  40
ALA X  41
GLY X 210
ILE X 209
None
0.60A 5kr1B-4yahX:
undetectable
5kr1B-4yahX:
17.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
4 GLY A  34
ALA A  35
ASP A  36
GLY A  58
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
0.53A 5kr1B-4ydfA:
12.5
5kr1B-4ydfA:
32.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
4 GLY A  34
ALA A  35
ASP A  36
VAL A  39
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
None
0.39A 5kr1B-4ydfA:
12.5
5kr1B-4ydfA:
32.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z0t OXIDOREDUCTASE,
SHORT-CHAIN
DEHYDROGENASE/REDUCT
ASE FAMILY


(Brucella ovis)
PF00106
(adh_short)
4 GLY A  93
ALA A  92
GLY A  20
ILE A  19
None
BR  A 305 (-3.6A)
None
BR  A 304 (-4.5A)
0.64A 5kr1B-4z0tA:
undetectable
5kr1B-4z0tA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z1p CELL WALL SURFACE
ANCHOR PROTEIN


(Streptococcus
agalactiae)
PF16364
(Antigen_C)
4 GLY A 291
ALA A 292
ASP A 293
GLY A 254
None
0.67A 5kr1B-4z1pA:
undetectable
5kr1B-4z1pA:
13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z23 CELL WALL SURFACE
ANCHOR PROTEIN


(Streptococcus
agalactiae)
PF16364
(Antigen_C)
4 GLY A 291
ALA A 292
ASP A 293
GLY A 254
None
0.66A 5kr1B-4z23A:
undetectable
5kr1B-4z23A:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z8x ATP-DEPENDENT ZINC
METALLOPROTEASE FTSH


(Aquifex
aeolicus)
PF00004
(AAA)
PF01434
(Peptidase_M41)
4 GLY A 492
ALA A 493
ASP A 496
ILE A 417
None
None
ZN  A 701 (-2.2A)
None
0.63A 5kr1B-4z8xA:
undetectable
5kr1B-4z8xA:
12.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASN A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
None
0.56A 5kr1B-5b18A:
18.5
5kr1B-5b18A:
71.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b7n MTA/SAH NUCLEOSIDASE

(Aeromonas
hydrophila)
PF01048
(PNP_UDP_1)
4 ASN A 125
GLY A 127
ALA A 128
VAL A 150
None
0.42A 5kr1B-5b7nA:
undetectable
5kr1B-5b7nA:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bqn BOTULINUM NEUROTOXIN
TYPE D,BOTULINUM
NEUROTOXIN TYPE D


(Clostridium
botulinum)
PF01742
(Peptidase_M27)
PF07952
(Toxin_trans)
5 GLY A 668
ASP A 548
VAL A 547
GLY A 645
ILE A 644
None
1.49A 5kr1B-5bqnA:
undetectable
5kr1B-5bqnA:
8.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cej 3-OXOACYL-[ACYL-CARR
IER PROTEIN]
REDUCTASE


(Yersinia pestis)
PF13561
(adh_short_C2)
4 GLY A  88
ALA A  87
GLY A  18
ILE A  17
None
0.65A 5kr1B-5cejA:
undetectable
5kr1B-5cejA:
19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5esc HUPZ

(Streptococcus
sp. 'group A')
PF01243
(Putative_PNPOx)
4 GLY A  60
VAL A  17
GLY A 108
ILE A 109
None
0.56A 5kr1B-5escA:
undetectable
5kr1B-5escA:
25.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ez7 FLAVOENZYME PA4991

(Pseudomonas
aeruginosa)
PF01266
(DAO)
4 ASN A 209
GLY A 206
ALA A 205
GLY A  18
None
FAD  A 401 (-3.8A)
FAD  A 401 (-3.7A)
None
0.65A 5kr1B-5ez7A:
undetectable
5kr1B-5ez7A:
16.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fir 5'-3'
EXORIBONUCLEASE 2
HOMOLOG


(Caenorhabditis
elegans)
PF03159
(XRN_N)
4 GLY A 232
ASP A 234
ASP A 236
GLY A 205
None
0.63A 5kr1B-5firA:
undetectable
5kr1B-5firA:
10.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fok IRON TRANSPORT OUTER
MEMBRANE RECEPTOR


(Pseudomonas
aeruginosa)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
4 GLY A 217
ASP A 219
GLY A 181
ILE A 180
None
0.66A 5kr1B-5fokA:
undetectable
5kr1B-5fokA:
8.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g56 CARBOHYDRATE BINDING
FAMILY 6


(Ruminiclostridium
thermocellum)
PF00150
(Cellulase)
PF03422
(CBM_6)
5 GLY A 372
ALA A 363
VAL A 437
GLY A 566
ILE A 516
None
1.12A 5kr1B-5g56A:
undetectable
5kr1B-5g56A:
8.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gw7 GLUCOSIDASE YGJK

(Escherichia
coli)
PF01204
(Trehalase)
4 GLY A 626
ASP A 605
GLY A 507
ILE A 509
None
0.66A 5kr1B-5gw7A:
undetectable
5kr1B-5gw7A:
9.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i5l BACTERIOPHYTOCHROME
PROTEIN


(Agrobacterium
fabrum)
PF00360
(PHY)
PF01590
(GAF)
PF08446
(PAS_2)
4 GLY A 357
ALA A 358
ASP A 359
GLY A 418
None
0.58A 5kr1B-5i5lA:
undetectable
5kr1B-5i5lA:
12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j6f 3-DEOXY-D-ARABINO-HE
PTULOSONATE
7-PHOSPHATE
SYNTHASE, CHORISMATE
MUTASE-ISOZYME 3


(Geobacillus sp.
GHH01)
PF00793
(DAHP_synth_1)
PF01817
(CM_2)
4 GLY A 315
ALA A 316
ASP A 317
ILE A 281
None
0.61A 5kr1B-5j6fA:
undetectable
5kr1B-5j6fA:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j8j HISTONE DEACETYLASE
HDA1


(Saccharomyces
cerevisiae)
PF09757
(Arb2)
4 GLY A 679
ASP A 624
GLY A 596
ILE A 595
None
0.64A 5kr1B-5j8jA:
undetectable
5kr1B-5j8jA:
18.33